Johnson Health Tech .Co., Ltd. (1736.TW)
TWD 181.0
(-2.16%)
TWD 181.0
(-2.16%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 4.06 Billion | 392.45 Million | -3.53 Billion | 2.94 Billion | 943.23 Million | 980.67 Million |
| Net Income | 709.82 Million | 303.6 Million | 163.7 Million | 975.33 Million | 1.61 Billion | 292.85 Million |
| Depreciation & Amortization | 1.39 Billion | 1.2 Billion | 1.04 Billion | 984 Million | 876.53 Million | 395.94 Million |
| Deferred income taxes | - | - | 80.37 Million | -117.86 Million | -271.11 Million | - |
| Stock-based compensation | - | - | 4.34 Million | 706 Thousand | 9.97 Million | - |
| Change in working capital | 1.36 Billion | -982.93 Million | -4.83 Billion | 1.11 Billion | -1.2 Billion | 495.59 Million |
| Other non-cash items | 592.73 Million | -134.79 Million | 11.06 Million | -17.21 Million | -85.64 Million | -203.72 Million |
| Investing Cash Flow | -680.81 Million | -667.72 Million | -721.77 Million | -2.58 Billion | -512.57 Million | -601.19 Million |
| Investments in PPE | -707.14 Million | -440.85 Million | -760.16 Million | -839.92 Million | -710.33 Million | -632.2 Million |
| Acquisitions | 25.88 Million | -251.44 Million | 11.8 Million | -1.75 Billion | 196.98 Million | 31 Million |
| Investment purchases | 30.82 Million | -548 Thousand | -12.42 Million | -570 Thousand | - | - |
| Sales/Maturities of investments | 441 Thousand | 548 Thousand | 617 Thousand | 570 Thousand | - | - |
| Other Investing Activities | -30.82 Million | 24.56 Million | 38.39 Million | 16 Million | 775 Thousand | 31 Million |
| Financing Cash Flow | -4.09 Billion | 846.52 Million | 3.98 Billion | -417.85 Million | 84.01 Million | -350.99 Million |
| Debt repayment | -3.14 Billion | -309.68 Million | -11.29 Billion | -17.22 Billion | -99.47 Million | -11.38 Billion |
| Dividends payments | -181.75 Million | -151.29 Million | -338.89 Million | -424.16 Million | -197.35 Million | -90.93 Million |
| Common Stock Repurchased | - | - | - | -32.3 Million | -47.83 Million | - |
| Common Stock Issuance | - | 20.26 Million | - | 6.26 Million | 10.52 Million | - |
| Other Financing Activities | -769.21 Million | 1.3 Billion | 15.61 Billion | 17.25 Billion | 229.72 Million | 11.12 Billion |
| Accounts receivables | -1.13 Billion | -1.86 Billion | -1.07 Billion | 936.21 Million | -36.67 Million | -536.86 Million |
| Accounts payables | -202.49 Million | 111.9 Million | -145.67 Million | 803.7 Million | -145.11 Million | 1.02 Billion |
| Inventory | 2.76 Billion | -134.18 Million | -3.72 Billion | -666.89 Million | -1.03 Billion | -639.89 Million |
| Other working capital | -65.02 Million | 902.92 Million | 114.43 Million | 43.79 Million | 11.85 Million | 1.13 Billion |
| Cash at beginning of period | 3.53 Billion | 2.61 Billion | 3.29 Billion | 3.28 Billion | 3.25 Billion | 3.38 Billion |
| Cash at end of period | 2.34 Billion | 3.53 Billion | 2.61 Billion | 3.29 Billion | 3.28 Billion | 3.25 Billion |
| Capital Expenditure | -707.14 Million | -440.85 Million | -760.16 Million | -839.92 Million | -710.33 Million | -632.2 Million |
| Effect of forex changes on cash | -480.79 Million | 345.22 Million | -402.08 Million | 71.86 Million | -486.66 Million | -164.17 Million |
| Net cash flow / Change in cash | -1.19 Billion | 916.47 Million | -677.72 Million | 12.32 Million | 27.99 Million | -135.68 Million |
| Free Cash Flow | 3.35 Billion | -48.4 Million | -4.29 Billion | 2.1 Billion | 232.89 Million | 348.46 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 292.08 Million | -137.9 Million | 653.71 Million | 709.82 Million | 561.4 Million | 483.65 Million |
| Depreciation & Amortization | 397.11 Million | 409.62 Million | 358.86 Million | 1.39 Billion | 384.88 Million | 342.32 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -807.12 Million | 275.07 Million | 1.06 Billion | 1.36 Billion | 70.01 Million | 196.14 Million |
| Other non-cash items | 2.65 Billion | -11.14 Million | 481.35 Million | 592.73 Million | -117.88 Million | -65.17 Million |
| Investing Cash Flow | -150.15 Million | -161.44 Million | -269.3 Million | -680.81 Million | -140.85 Million | -212.32 Million |
| Investments in PPE | -153 Million | -193.28 Million | -273.3 Million | -707.14 Million | -148.09 Million | -215.86 Million |
| Acquisitions | 2.93 Million | 31.75 Million | 3.82 Million | 25.88 Million | 7.24 Million | 3.42 Million |
| Investment purchases | - | - | 10.91 Million | 30.82 Million | - | -3.54 Million |
| Sales/Maturities of investments | -90 Thousand | 90 Thousand | 183 Thousand | 441 Thousand | - | 119 Thousand |
| Other Investing Activities | -7.3 Million | 3.82 Million | -10.91 Million | -30.82 Million | -4.78 Million | 3.54 Million |
| Financing Cash Flow | 551.54 Million | -418.54 Million | -1.76 Billion | -4.09 Billion | -814.64 Million | -1.27 Billion |
| Debt repayment | -1.05 Billion | -222.85 Million | -1.35 Billion | -3.14 Billion | -14.94 Billion | -19.22 Billion |
| Dividends payments | -302.92 Million | - | -181.75 Million | -181.75 Million | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -197.13 Million | -195.68 Million | -228.58 Million | -769.21 Million | 14.12 Billion | 17.94 Billion |
| Accounts receivables | -669.78 Million | 1.75 Billion | -1.87 Billion | -1.13 Billion | -951.32 Million | -203.28 Million |
| Accounts payables | 829.5 Million | -293.53 Million | -288.09 Million | -202.49 Million | 1.58 Billion | -241.59 Million |
| Inventory | -2 Billion | -619.5 Million | 1.95 Billion | 2.76 Billion | -669.43 Million | 1.01 Billion |
| Other working capital | 1.03 Billion | -564.64 Million | 1.27 Billion | -65.02 Million | 108.46 Million | -371.12 Million |
| Cash at beginning of period | 2.43 Billion | 2.34 Billion | 2.21 Billion | 3.53 Billion | 2.31 Billion | 2.77 Billion |
| Cash at end of period | 2.49 Billion | 2.43 Billion | 2.34 Billion | 2.34 Billion | 2.21 Billion | 2.31 Billion |
| Capital Expenditure | -153 Million | -193.28 Million | -273.3 Million | -707.14 Million | -148.09 Million | -215.86 Million |
| Effect of forex changes on cash | -239.89 Million | 121.33 Million | -399.12 Million | -480.79 Million | -41.59 Million | 64.85 Million |
| Net cash flow / Change in cash | 60.18 Million | 97.49 Million | 124.61 Million | -1.19 Billion | -98.66 Million | -463.79 Million |
| Free Cash Flow | -254.31 Million | 362.84 Million | 2.28 Billion | 3.35 Billion | 750.33 Million | 741.07 Million |
CGROF
6155
CRCBY
CK-R
300756
BGD